Litcius/Paper detail

Early Time-to-Tocilizumab after B Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy in Myeloma

Rahul Banerjee, Jeffrey Marsal, Chiung‐Yu Huang, Mimi Lo, Swetha Kambhampati Thiruvengadam, Vanessa E. Kennedy, Shagun Arora, Jeffrey L. Wolf, Thomas Martin, Sandy W. Wong, Nina Shah

2021Transplantation and Cellular Therapy49 citationsDOI

Topics & Concepts

Chimeric antigen receptorTocilizumabMedicineAntigenMultiple myelomaImmunologyReceptorCancer researchVirologyT cellInternal medicineImmune systemRheumatoid arthritisCAR-T cell therapy researchVirus-based gene therapy researchViral Infectious Diseases and Gene Expression in Insects
Early Time-to-Tocilizumab after B Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy in Myeloma | Litcius